Physician profile
Wendy Mcclain
NPI 1154640878
$7,225.74
in general payments reported to CMS, 2019-2025
13 companies · $222 in 2025
The $222 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,230 · 2020: $828 · 2021: $1,219 · 2022: $96.64 · 2023: $138 · 2024: $492 · 2025: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $852.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $852.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gentleman Orthopedic Solutions | $3,174.05 | 2019-2021 | |
| Arthrex, INC. | $2,986.41 | 2019-2020 | |
| Stryker Corporation | $265.49 | 2022-2024 | Salvation, Augment Injectable, Easyfuse |
| Convatec INC. | $165.31 | 2020-2024 | |
| Organogenesis INC. | $163.83 | 2024-2025 | Via Matrix, Puraply Am |
| Treace Medical Concepts, INC. | $163.27 | 2025 | |
| Smith+Nephew, INC. | $91.40 | 2019-2025 | Stravix, Grafix Pl, Grafix |
| Heron Therapeutics, INC. | $79.84 | 2023 | Zynrelef |
| Averitas Pharma INC. | $58.00 | 2023 | Qutenza |
| Horizon Therapeutics Plc | $28.57 | 2019 | |
| Fidia Pharma USA INC. | $18.99 | 2021 | |
| Paratek Pharmaceuticals, INC. | $16.67 | 2025 | Nuzyra |
| Kci USA, INC. | $13.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wendy Mcclain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.